Capital Fund Management S.A. Abb Vie Inc. Put Options Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $7.96 Million - $9.69 Million	-48,600 Reduced 14.99%	275,600 $54.4 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $3.42 Million - $3.99 Million	-22,100 Reduced 6.38%	324,200 $55.6 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $46.7 Million - $53.2 Million	292,400 Added 542.49%	346,300 $63.1 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $22.6 Million - $25.4 Million	-164,100 Reduced 75.28%	53,900 $8.35 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $10.4 Million - $12.1 Million	78,200 Added 55.94%	218,000 $32.5 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $2.72 Million - $3.38 Million	20,500 Added 17.18%	139,800 $18.8 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $26.5 Million - $30.5 Million	-183,000 Reduced 60.54%	119,300 $19 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $34.2 Million - $41.1 Million	-247,600 Reduced 45.03%	302,300 $48.9 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $9.96 Million - $11.4 Million	74,200 Added 15.6%	549,900 $73.8 Billion
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $19.7 Million - $25.1 Million	143,400 Added 43.15%	475,700 $72.9 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $38.9 Million - $48.3 Million	294,700 Added 783.78%	332,300 $53.9 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $1.53 Million - $1.93 Million	14,200 Added 60.68%	37,600 $5.09 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $2.79 Million - $3.16 Million	-26,200 Reduced 52.82%	23,400 $2.52 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $18.1 Million - $20.2 Million	-172,500 Reduced 77.67%	49,600 $5.59 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $3.68 Million - $4.05 Million	35,962 Added 19.32%	222,100 $24 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $7.74 Million - $10.4 Million	-96,100 Reduced 34.05%	186,138 $19.9 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $103,092 - $120,996	1,200 Added 0.43%	282,238 $24.7 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $12.7 Million - $17 Million	172,738 Added 159.5%	281,038 $27.6 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $135,450 - $205,359	-2,100 Reduced 1.9%	108,300 $8.25 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $5.94 Million - $7.43 Million	82,300 Added 292.88%	110,400 $9.78 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $2.99 Million - $3.59 Million	-47,400 Reduced 62.78%	28,100 $2.13 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $2.05 Million - $2.62 Million	-31,200 Reduced 29.24%	75,500 $5.49 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $16.7 Million - $19.7 Million	-217,000 Reduced 67.04%	106,700 $8.6 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $27.2 Million - $33.5 Million	-349,200 Reduced 51.89%	323,700 $29.8 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $684,607 - $761,068	-7,700 Reduced 1.13%	672,900 $63.6 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $13 Million - $15.4 Million	-144,600 Reduced 17.52%	680,600 $63.1 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $12.4 Million - $16.5 Million	-134,300 Reduced 14.0%	825,200 $78.1 Million
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $57.7 Million - $63.3 Million	644,300 Added 204.41%	959,500 $92.8 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $22 Million - $28.1 Million	315,200	315,200 $28 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account